Long chain antigen containing interepitope sequence that promotes antigen presentation to T cells
US11179450B2 · kind B2 · utility
0Cited by
4References
23Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 16, 2018 |
| Grant date | Nov 23, 2021 |
| Priority date | — |
| Expiry date | Jan 6, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A long-chain peptide antigen includes a plurality of epitopes. An interepitope sequence located between two of the plurality of epitopes contains four to ten consecutive tyrosines. The long-chain peptide antigen may be administered to a patient together with a hydrophobized polysaccharide, such as cholesterol-modified pullulan, and/or an adjuvant, such as CpG oligo DNA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.